NewAmsterdam Pharma Company NAMS Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by NewAmsterdam Pharma Company in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The official record: NewAmsterdam Pharma Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about NewAmsterdam Pharma Company's comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NewAmsterdam Pharma Company's comprehensive income (loss), net of tax, attributable to parent?
- NewAmsterdam Pharma Company (NAMS) reported comprehensive income (loss), net of tax, attributable to parent of -$49.01M in Q1 2026.
- How has NewAmsterdam Pharma Company's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- NewAmsterdam Pharma Company's comprehensive income (loss), net of tax, attributable to parent decreased by 23.9% year-over-year, from -$39.56M to -$49.01M.
- What is the long-term trend for NewAmsterdam Pharma Company's comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), NewAmsterdam Pharma Company's comprehensive income (loss), net of tax, attributable to parent has grown at a 48.8% compound annual growth rate (CAGR), from -$41.5M to -$203.49M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric represents the total change in equity during a period resulting from transactions and other events from non-owner sources, including net income and other comprehensive income items. It provides a comprehensive view of the company's financial performance by incorporating unrealized gains or losses that are typically excluded from the standard income statement. Investors use this to assess the total impact of market fluctuations and accounting adjustments on the company's net worth.